Fiduciary Family Office LLC Lowers Stock Position in STERIS plc $STE

Fiduciary Family Office LLC cut its stake in shares of STERIS plc (NYSE:STE) by 45.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,752 shares of the medical equipment provider’s stock after selling 2,333 shares during the quarter. Fiduciary Family Office LLC’s holdings in STERIS were worth $681,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Mediolanum International Funds Ltd grew its holdings in STERIS by 9.0% in the 2nd quarter. Mediolanum International Funds Ltd now owns 62,327 shares of the medical equipment provider’s stock worth $14,883,000 after acquiring an additional 5,156 shares during the last quarter. Entropy Technologies LP boosted its holdings in shares of STERIS by 282.2% during the second quarter. Entropy Technologies LP now owns 9,099 shares of the medical equipment provider’s stock worth $2,186,000 after purchasing an additional 6,718 shares during the period. Vanguard Group Inc. boosted its holdings in shares of STERIS by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,163,128 shares of the medical equipment provider’s stock worth $2,921,827,000 after purchasing an additional 205,276 shares during the period. Asset Management One Co. Ltd. grew its stake in shares of STERIS by 5.4% in the third quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider’s stock worth $24,366,000 after purchasing an additional 5,072 shares during the last quarter. Finally, Cerity Partners LLC increased its holdings in STERIS by 28.8% during the 3rd quarter. Cerity Partners LLC now owns 96,853 shares of the medical equipment provider’s stock valued at $23,966,000 after purchasing an additional 21,656 shares during the period. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling

In other STERIS news, VP Julia Madsen sold 5,008 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the sale, the vice president owned 10,710 shares in the company, valued at approximately $2,806,020. This represents a 31.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Renato Tamaro sold 5,036 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the transaction, the vice president directly owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This represents a 46.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 25,044 shares of company stock valued at $6,586,218 over the last quarter. Corporate insiders own 1.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, STERIS has an average rating of “Moderate Buy” and an average target price of $273.50.

STERIS Price Performance

STE stock opened at $268.80 on Friday. STERIS plc has a 1 year low of $204.90 and a 1 year high of $269.44. The company has a market cap of $26.38 billion, a P/E ratio of 38.62 and a beta of 1.03. The firm has a 50-day moving average of $259.03 and a 200 day moving average of $246.66. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the previous year, the firm posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Tuesday, November 18th were given a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Tuesday, November 18th. STERIS’s dividend payout ratio (DPR) is 36.21%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.